GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase - Seite 2

With Pristina Bright, clinicians can see lesions that cannot be seen on routine mammography^{4 5 6} and biopsy what is seen within 15 minutes.⁷ To help improve overall productivity, Pristina Bright can also help providers take more patients on their system, with the ability to image up to 30 patients a day with contrast mammography⁸ through an easy-to-read exam.

“Through our research and clinical experiences, contrast enhanced mammography (CEM) continues to emerge as game-changer in helping to improve breast cancer outcomes for patients facing this difficult diagnosis,” shares Dr. Jordana Phillips – Radiologist at Boston Medical Center. “When it comes to findings that are difficult to define, CEM leverages the addition of a contrast agent to highlight unusual areas of blood flow - providing an efficient yet familiar, patient-centric approach to evaluate the presence of cancer with high sensitivity and specificity. With contrast, we’re able to turn a normal mammogram into something that provides so much more information which accelerates our ability to make a confident diagnosis. We’re excited to be joining GE HealthCare and the breast imaging community at SBI 2024 to share more about our experience through the hands-on learning course, as well as share how we’ve implemented CEM as part of our efforts to provide personalized breast cancer care to community we serve.”

As part of the company’s commitment to enabling access to healthcare, GE HealthCare will have its mobile mammography showcase onsite. Attendees will have the unique opportunity to explore the capabilities of this unit designed to offer convenient screening set-up within the familiar environment of a workplace. The truck is equipped with the Senographe Pristina and Invenia ABUS to ensure accurate and efficient screenings.

Visit booth 301 to learn more about GE HealthCare’s personalized breast cancer screening solutions, including:

• Senographe Pristina, a mammography system designed to provide a better patient experience and optimized for rapid diagnosis;
• Invenia ABUS, the first FDA-approved automatic breast ultrasound supplemental screening specifically designed for detecting cancer in dense breast;
• SenoBright HD Contrast Enhanced Mammography (CEM), which combines mammography and vascular-based screening methods to highlight areas of unusual blood-flow patterns that may indicate malignancy - helping reduce the masking effect of fibro glandular breast tissue so lesions can be more clearly identifiable; and
• Serena Bright, the industry’s first contrast-guided biopsy solution which transforms the screening room into an interventional suite if medical indications recommend pathology.

*MyBreastAI suite is a commercial offering that includes GE HealthCare’s Edison Health Services platform, ProFound AI for DBT, SecondLook for 2D Mammography and PowerLook Density Assessment. These applications are provided by iCAD. MyBreastAI Suite is compatible with the latest versions of iCAD, Inc. as of November 14, 2023.